Pacific Biosciences of California Inc
NASDAQ:PACB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pacific Biosciences of California Inc
NASDAQ:PACB
|
US |
|
ACS Actividades de Construccion y Servicios SA
OTC:ACSAF
|
ES |
|
S
|
SF Real Estate Investment Trust
F:8ET
|
HK |
|
V
|
VICI Properties Inc
XMUN:1KN
|
US |
|
T
|
Tenable Holdings Inc
F:TE7
|
US |
|
C
|
Coca-Cola Co
XMUN:CCC3
|
US |
|
L
|
Lands End Inc
F:LED
|
US |
|
L
|
L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes Georges Claude SA
XHAM:AIL
|
FR |
|
A
|
Accenture PLC
XMUN:CSA
|
IE |
|
L
|
L'Oreal SA
XMUN:LOR
|
FR |
|
H
|
Hmt Xiamen New Technical Materials Co Ltd
SSE:603306
|
CN |
|
G
|
Guangdong Investment Ltd
XMUN:GUG
|
HK |
|
O
|
Orlen SA
PSE:PKN
|
PL |
|
Exelon Corp
NASDAQ:EXC
|
US |
|
R
|
Rewalk Robotics Ltd
SWB:2RW
|
IL |
|
Omnicell Inc
NASDAQ:OMCL
|
US |
|
National Energy Services Reunited Corp
NASDAQ:NESR
|
US |
|
C
|
Credit Suisse Group AG
F:CSX
|
CH |
|
OFS Capital Corp
NASDAQ:OFS
|
US |
|
U
|
U Power Ltd
NASDAQ:UCAR
|
CN |
Wall St Price Targets
PACB Price Targets Summary
Pacific Biosciences of California Inc
According to Wall Street analysts, the average 1-year price target for PACB is 2.34 USD with a low forecast of 1.26 USD and a high forecast of 3.15 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PACB's stock price target?
Price Target
2.34
USD
According to Wall Street analysts, the average 1-year price target for PACB is 2.34 USD with a low forecast of 1.26 USD and a high forecast of 3.15 USD.
What is the Revenue forecast for Pacific Biosciences of California Inc?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 8 years is 17%.
What is the Gross Profit forecast for Pacific Biosciences of California Inc?
Projected CAGR
26%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 36%. The projected CAGR for the next 3 years is 26%.
